ArticleInfection and immunity2003

Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.

Luciano Polonelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.